Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(25.0%)
USD 0.01
(25.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.69 Million USD | -247.88% |
| 2022 | 998 Thousand USD | 1701.39% |
| 2021 | 23 Thousand USD | 87.98% |
| 2020 | -491 Thousand USD | -134.9% |
| 2019 | -255 Thousand USD | -8600.0% |
| 2018 | 3000.00 USD | -97.25% |
| 2017 | 109 Thousand USD | 145.04% |
| 2016 | -323 Thousand USD | -231.52% |
| 2015 | 184 Thousand USD | 141.91% |
| 2014 | -439 Thousand USD | -745.59% |
| 2013 | 68 Thousand USD | 54.55% |
| 2012 | 45 Thousand USD | 123.28% |
| 2011 | -189 Thousand USD | 33.68% |
| 2010 | -284 Thousand USD | -319.12% |
| 2009 | -78 Thousand USD | 84.44% |
| 2008 | -437 Thousand USD | 39.56% |
| 2007 | -704 Thousand USD | 72.63% |
| 2006 | -2.64 Million USD | -285.13% |
| 2005 | -768 Thousand USD | -42.03% |
| 2004 | -483 Thousand USD | 34.2% |
| 2003 | -734 Thousand USD | -158.45% |
| 2002 | -331 Thousand USD | 85.05% |
| 2001 | -1.9 Million USD | 14.68% |
| 2000 | -2.22 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -163 Thousand USD | 24.54% |
| 2023 Q2 | -737 Thousand USD | -154.14% |
| 2023 Q1 | -290 Thousand USD | -55.91% |
| 2023 FY | - USD | -247.88% |
| 2023 Q4 | -216 Thousand USD | 53.25% |
| 2023 Q3 | -462 Thousand USD | 37.31% |
| 2022 Q2 | 356 Thousand USD | -52.97% |
| 2022 FY | - USD | 1701.39% |
| 2022 Q3 | 115 Thousand USD | -67.7% |
| 2022 Q1 | 757 Thousand USD | 151.5% |
| 2022 Q4 | -186 Thousand USD | -261.74% |
| 2021 Q4 | 301 Thousand USD | 344.72% |
| 2021 Q1 | -27 Thousand USD | 0.0% |
| 2021 Q2 | -224 Thousand USD | -729.63% |
| 2021 FY | - USD | 87.98% |
| 2021 Q3 | -123 Thousand USD | 45.09% |
| 2020 FY | - USD | -134.9% |
| 2019 FY | - USD | -8600.0% |
| 2018 Q2 | 16 Thousand USD | 123.19% |
| 2018 FY | - USD | -97.25% |
| 2018 Q1 | -69 Thousand USD | 0.0% |
| 2017 Q3 | -51 Thousand USD | 19.05% |
| 2017 FY | - USD | 145.04% |
| 2017 Q2 | -63 Thousand USD | -80.0% |
| 2017 Q1 | -35 Thousand USD | 75.0% |
| 2016 Q3 | -121 Thousand USD | -35.96% |
| 2016 Q1 | 27 Thousand USD | 158.7% |
| 2016 Q4 | -140 Thousand USD | -15.7% |
| 2016 Q2 | -89 Thousand USD | -429.63% |
| 2016 FY | - USD | -231.52% |
| 2015 Q4 | -46 Thousand USD | -140.71% |
| 2015 Q3 | 113 Thousand USD | 197.37% |
| 2015 FY | - USD | 141.91% |
| 2015 Q2 | 38 Thousand USD | -51.28% |
| 2015 Q1 | 78 Thousand USD | 127.37% |
| 2014 FY | - USD | -745.59% |
| 2014 Q2 | -56 Thousand USD | -5700.0% |
| 2014 Q1 | 1000.00 USD | 103.57% |
| 2014 Q4 | -285 Thousand USD | -187.88% |
| 2014 Q3 | -99 Thousand USD | -76.79% |
| 2013 Q1 | 65 Thousand USD | -5.8% |
| 2013 Q2 | 11 Thousand USD | -83.08% |
| 2013 FY | - USD | 54.55% |
| 2013 Q4 | -28 Thousand USD | -240.0% |
| 2013 Q3 | 20 Thousand USD | 81.82% |
| 2012 Q2 | -2000.00 USD | 85.71% |
| 2012 Q1 | -14 Thousand USD | 72.55% |
| 2012 FY | - USD | 123.28% |
| 2012 Q4 | 69 Thousand USD | 962.5% |
| 2012 Q3 | -8000.00 USD | -300.0% |
| 2011 Q3 | -61 Thousand USD | 35.79% |
| 2011 Q2 | -95 Thousand USD | -658.82% |
| 2011 Q1 | 17 Thousand USD | 106.3% |
| 2011 FY | - USD | 33.68% |
| 2011 Q4 | -51 Thousand USD | 16.39% |
| 2010 Q2 | -42 Thousand USD | -700.0% |
| 2010 Q4 | -270 Thousand USD | -1385.71% |
| 2010 Q3 | 21 Thousand USD | 150.0% |
| 2010 Q1 | 7000.00 USD | 187.5% |
| 2010 FY | - USD | -319.12% |
| 2009 Q3 | -41 Thousand USD | -20.59% |
| 2009 FY | - USD | 84.44% |
| 2009 Q2 | -34 Thousand USD | -750.0% |
| 2009 Q4 | -8000.00 USD | 80.49% |
| 2009 Q1 | -4000.00 USD | 97.81% |
| 2008 FY | - USD | 39.56% |
| 2008 Q3 | -33 Thousand USD | 79.25% |
| 2008 Q2 | -159 Thousand USD | -152.38% |
| 2008 Q1 | -63 Thousand USD | 81.36% |
| 2008 Q4 | -183 Thousand USD | -454.55% |
| 2007 FY | - USD | 72.63% |
| 2007 Q4 | -338 Thousand USD | -111.25% |
| 2007 Q3 | -160 Thousand USD | -185.71% |
| 2007 Q2 | -56 Thousand USD | 66.86% |
| 2007 Q1 | -169 Thousand USD | 86.9% |
| 2006 Q1 | -344 Thousand USD | 50.72% |
| 2006 FY | - USD | -285.13% |
| 2006 Q4 | -1.29 Million USD | -170.44% |
| 2006 Q3 | -477 Thousand USD | 10.51% |
| 2006 Q2 | -533 Thousand USD | -54.94% |
| 2005 Q3 | 182 Thousand USD | 162.98% |
| 2005 Q4 | -698 Thousand USD | -483.52% |
| 2005 Q2 | -289 Thousand USD | -881.08% |
| 2005 Q1 | 37 Thousand USD | 107.41% |
| 2005 FY | - USD | -42.03% |
| 2004 FY | - USD | 34.2% |
| 2004 Q2 | 100 Thousand USD | 127.27% |
| 2004 Q3 | -204 Thousand USD | -304.0% |
| 2004 Q4 | -499 Thousand USD | -144.61% |
| 2004 Q1 | 44 Thousand USD | 117.53% |
| 2003 Q2 | -671 Thousand USD | -398.25% |
| 2003 Q1 | 57 Thousand USD | 130.48% |
| 2003 Q3 | 131 Thousand USD | 177.06% |
| 2003 FY | - USD | -158.45% |
| 2003 Q4 | -251 Thousand USD | -291.6% |
| 2002 Q3 | -256 Thousand USD | -227.36% |
| 2002 Q1 | -43 Thousand USD | 69.29% |
| 2002 FY | - USD | 85.05% |
| 2002 Q4 | -209 Thousand USD | 26.95% |
| 2002 Q2 | 176 Thousand USD | 567.44% |
| 2001 Q3 | -440 Thousand USD | 50.23% |
| 2001 Q4 | -140 Thousand USD | 68.18% |
| 2001 FY | - USD | 14.68% |
| 2001 Q1 | -436 Thousand USD | 0.0% |
| 2001 Q2 | -884 Thousand USD | -102.75% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | -606 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 79.605% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -2.84 Million USD | 40.345% |
| Cannabis Sativa, Inc. | -1.11 Million USD | -52.351% |
| CompuMed, Inc. | 690.19 Thousand USD | 346.019% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.798% |
| Cogstate Limited | 9.89 Million USD | 117.167% |
| CareView Communications, Inc. | -210.04 Thousand USD | -708.414% |
| Craneware plc | 54.26 Million USD | 103.129% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 86.187% |
| Certive Solutions Inc. | -704.66 Thousand USD | -140.966% |
| Drug Free Solution, Inc. | -1.39 Million USD | -21.727% |
| DATATRAK International, Inc. | 2.72 Million USD | 162.231% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -2488.02% |
| Healixa Inc. | -6.32 Million USD | 73.134% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 116.698% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -299.071% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | -358.482% |
| Cannabiz Mobile, Inc. | -750.00 USD | -226300.0% |
| Mednow Inc. | -28.12 Million USD | 93.962% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -527.209% |
| MediXall Group, Inc. | -6.52 Million USD | 73.971% |
| Mitesco, Inc. | -11.96 Million USD | 85.807% |
| MobileSmith, Inc. | -13.83 Million USD | 87.729% |
| NantHealth, Inc. | -38.53 Million USD | 95.594% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 85.951% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 85.965% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 229.447% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 2372.18% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -13836.31% |
| Renalytix Plc | -28.52 Million USD | 94.046% |
| Revium Recovery Inc. | -678 Thousand USD | -150.442% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -460062.602% |
| Vaso Corporation | 4.19 Million USD | 140.477% |
| Vynleads, Inc. | -235.72 Thousand USD | -620.328% |